- By insider

Interim CEO of Zosano Pharma Corp (ZSAN) John Peter Walker bought 73,716 shares of ZSAN on 05/25/2017 at an average price of $1.36 a share. The total cost of this purchase was $100,254.

Zosano Pharma Corp is a clinical stage specialty pharmaceutical company. It develops a proprietary transdermal microneedle patch system to deliver its proprietary formulations of existing drugs through the skin for the treatment of various indications. Zosano Pharma Corp has a market cap of $52.150 million; its shares were traded at around $1.33 .

• Warning! GuruFocus has detected 2 Warning Signs with ZSAN. Click here to check it out.

• ZSAN 15-Year Financial Data

• The intrinsic value of ZSAN

• Peter Lynch Chart of ZSAN

CEO Recent Trades:

• Interim CEO John Peter Walker bought 73,716 shares of ZSAN stock on 05/25/2017 at the average price of $1.36. The price of the stock has decreased by 2.21% since.

CFO Recent Trades:

• CFO and Chief Business Officer Georgia Erbez bought 68,000 shares of ZSAN stock on 05/25/2017 at the average price of $1.32. The price of the stock has increased by 0.76% since.

For the complete insider trading history of ZSAN, click here

.This article first appeared on GuruFocus.

• Warning! GuruFocus has detected 2 Warning Signs with ZSAN. Click here to check it out.

• ZSAN 15-Year Financial Data

• The intrinsic value of ZSAN

• Peter Lynch Chart of ZSAN